The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Celgene (Inst); Lilly (Inst); Puma Biotechnology (Inst)
ALLELE: A consortium for prospective genomics and functional diagnostics to guide patient care and trial analysis in newly-diagnosed glioblastoma.
 
Mehdi Touat
Travel, Accommodations, Expenses - Merck Sharp & Dohme
 
Adrian M. Dubuc
Travel, Accommodations, Expenses - Agilent
 
David M. Meredith
No Relationships to Disclose
 
Sarah C. Gaffey
No Relationships to Disclose
 
Jack E. Gedulig
No Relationships to Disclose
 
Shakti H. Ramkissoon
Employment - Foundation Medicine
Stock and Other Ownership Interests - Foundation Medicine
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I); ZIOPHARM Oncology (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences; ZIOPHARM Oncology (I)
Consulting or Advisory Role - Abbvie; AstraZeneca; Boston Biomedical; CarThera; Celldex; Deciphera; Five Prime Therapeutics; Foundation Medicine; Genentech/Roche; GW Pharmaceuticals; Insys Therapeutics; Kadmon; Merck; Novogen; Omniox; Oxigene; Vascular Biogenics
Research Funding - Deciphera; EMD Serono; Lilly; Mundipharma; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
 
Evanthia Galanis
Consulting or Advisory Role - Abbvie (Inst); Genentech/Roche (Inst); Oncorus
Research Funding - Genentech/Roche (Inst); Merck (Inst)
 
Mary Roberta Welch
Research Funding - Boston Biomedical
Travel, Accommodations, Expenses - Boston Biomedical
 
Louis B. Nabors
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb
Speakers' Bureau - Merck/Schering Plough
Travel, Accommodations, Expenses - Merck/Schering Plough
 
Isabel Arrillaga
Honoraria - Merck
Consulting or Advisory Role - Insys Therapeutics; Karus Therapeutics
 
E. Antonio Chiocca
Consulting or Advisory Role - Advantagene; Alcyone; DNAtrix; Tocagen; ZIOPHARM Oncology
 
Sandro Santagata
No Relationships to Disclose
 
David Schiff
No Relationships to Disclose
 
Manmeet Singh Ahluwalia
Honoraria - Elsevier; Itamar Medical (I); Prime Oncology
Consulting or Advisory Role - Abbvie; AstraZeneca; Bristol-Myers Squibb; CBT Pharmaceuticals; Monteris Medical
Research Funding - AstraZeneca; Boehringer Ingelheim; Lilly/ImClone; Novartis; Novocure; Spectrum Pharmaceuticals; TRACON Pharma
 
Howard Colman
Honoraria - Merck Sharp & Dohme
Consulting or Advisory Role - Abbvie; Genentech; Insys Therapeutics; Novocure; Omniox; Roche
Research Funding - Abbvie; BeiGene; DNAtrix; Kadmon; Merck; Newlink Genetics; Orbus Therapeutics; Plexxikon
 
Jan Drappatz
Stock and Other Ownership Interests - Bristol-Myers Squibb; Exelixis
Honoraria - UpToDate
Patents, Royalties, Other Intellectual Property - uptodate
 
Brian M. Alexander
No Relationships to Disclose
 
Patrick Y. Wen
Consulting or Advisory Role - AbbVie; Agios; AstraZeneca; Aurora Biopharma; Genentech/Roche; GW Pharmaceuticals; Immunomic Therapeutics; Kadmon; Karyopharm Therapeutics; Lilly; Monteris Medical; Vascular Biogenics; Vivus; ZIOPHARM Oncology
Speakers' Bureau - Merck
Research Funding - Abbvie (Inst); Agios (Inst); Angiochem (Inst); ARIAD (Inst); AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); ImmunoCellular Therapeutics (Inst); Karyopharm Therapeutics (Inst); Lilly; Merck (Inst); Novartis (Inst); Oncoceutics (Inst); Sanofi (Inst); Vascular Biogenics (Inst)
 
Keith L. Ligon
Stock and Other Ownership Interests - Travera
Consulting or Advisory Role - Midatech Pharma
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Plexxikon (Inst); Tragara (Inst); X4 Pharma (Inst)
Patents, Royalties, Other Intellectual Property - Molecular Diagnostics Assay Patent